EXPE vs TECH · P/E 20, rev $13.69B vs P/E 65, rev $1.22B
Expedia Group Inc. (EXPE) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported EXPE revenue for 2024-12-31 was $13.69B. Net income was $1.22B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the EXPE and TECH stock pages for the full models.
Not investment advice.